Synthesis, photophysical and photobiological characterization of BSA nanoparticles loaded with chloroaluminium phthalocyanine by one-step desolvation technique for photodynamic therapy action

References

• Zhang N, Zhao F, Zou Q, et al. Multitriggered tumor-responsive drug delivery vehicles based on protein and polypeptide coassembly for enhanced photodynamic tumor ablation. Small. 2016;12:5936–5943.
   PubMed Web of Science ®Google Scholar
• Wang C, Tao H, Cheng L, et al. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials. 2011;32:6145–6154.
   PubMed Web of Science ®Google Scholar
• Hayashi N, Kataoka H, Yano S, et al. A novel photodynamic therapy targeting cancer cells and tumor-associated macrophages. Mol Cancer Ther. 2015;14:452–460.
   PubMed Web of Science ®Google Scholar
• Ozog DM, Rkein AM, Fabi SG, et al. Photodynamic therapy: a clinical consensus guide. Dermatol Surg. 2016; 42: 804–827.
   PubMed Web of Science ®Google Scholar
• Babilas P, Schreml S, Landthaler M, et al. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed. 2010;26:118–132.
   PubMed Web of Science ®Google Scholar
• Lee Y, Baron ED. Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg. 2011;30:199–209.
   PubMed Web of Science ®Google Scholar
• Castilho-Fernandes A, Lopes TG, Primo FL, et al. Photodynamic process induced by chloro-aluminium phthalocyanine nanoemulsion in glioblastoma. Photodiagnosis Photodyn Ther. 2017;19:221–228.
   PubMed Web of Science ®Google Scholar
• Konan Y, Gurny R, Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B, Biol. 2002;66:89–106.
   PubMed Web of Science ®Google Scholar
• Szaciłowski K, Macyk W, Drzewiecka-Matuszek A, et al. Bioinorganic photochemistry: frontiers and mechanisms. Chem Rev. 2005;105:2647–2694.
   PubMed Web of Science ®Google Scholar
• Carvalho JA, Abreu AS, Ferreira VTP, et al. Preparation of gelatin nanoparticles by two step desolvation method for application in photodynamic therapy. J Biomater Sci Polym Ed. 2018;29:1287–1301.
   PubMed Web of Science ®Google Scholar
• Tiwari G, Tiwari R, Sriwastawa B, et al. Drug delivery systems: an updated review. Int J Pharm Investig. 2012;2:2–11.
   PubMedGoogle Scholar
• Jahanban-Esfahlan A, Dastmalchi S, Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol. 2016;91:703–709.
   PubMed Web of Science ®Google Scholar
• Narsireddy A, Vijayashree K, Adimoolam MG, et al. Photosensitizer and peptide-conjugated pamam dendrimer for targeted in vivo photodynamic therapy. Int J Nanomed. 2015;10:6865–6878.
   PubMed Web of Science ®Google Scholar
• Franchi LP, Amantino CF, Melo MT, et al. In vitro effects of photodynamic therapy induced by chloroaluminium phthalocyanine nanoemulsion. Photodiagnosis Photodyn Ther. 2016;16:100–105.
   PubMed Web of Science ®Google Scholar
• Simioni AR, Jesus PCC, Tedesco AC. Layer-by-layer hollow photosensitizer microcapsule design via manganese carbonate hard template for photodynamic therapy in cells. Photodiagnosis Photodyn Ther. 2018;22:169–177.
   PubMed Web of Science ®Google Scholar
• Gülseren I, Fang Y, Corredig M. Zinc incorporation capacity of whey protein nanoparticles prepare.,d with desolvation with ethanol. Food Chem. 2012;135:770–744.
   PubMed Web of Science ®Google Scholar
• Li S, Zou Q, Li Y, et al. Smart peptide-based supramolecular photodynamic metallo-nanodrugs designed by multicomponent coordination self-assembly. J Am Chem Soc. 2018;140:10794–10805.
   PubMed Web of Science ®Google Scholar
• Abbas M, Zou Q, Li S, et al. Self‐assembled peptide‐ and protein‐based nanomaterials for antitumor photodynamic and photothermal therapy. Adv Mater. 2017;29:1605021–1605036.
   Web of Science ®Google Scholar
• Zhao L, Liu Y, Chang R, et al. Supramolecular photothermal nanomaterials as an emerging paradigm toward precision cancer therapy. Adv Funct Mater. 2019;29:1806877–1806888.
   Web of Science ®Google Scholar
• Kolluru LP, Rizvi SAA, D´Souza M, et al. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. J Drug Target. 2013;21:77–86.
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157:168–182.
   PubMed Web of Science ®Google Scholar
• Ozgur A, Lambrecht FY, Ocakoglu K, et al. Synthesis and biological evaluation of radiolabeled photosensitizer linked bovine serum albumin nanoparticles as a tumor imaging agent. Int J Pharm. 2012;422:472–478.
   PubMed Web of Science ®Google Scholar
• Galisteo-González F, Molina-Bolívar JA. Systematic study on the preparation of BSA nanoparticles. Colloids Surf B. 2014;123:286–292.
   PubMed Web of Science ®Google Scholar
• Yedomon B, Fessi H, Charcosset C. Preparation of bovine serum albumin (BSA) nanoparticles by desolvation method using a membrane contactor: a new tool for large scale production. Eur J Pharm Biopharm. 2013;85:398–405.
   PubMed Web of Science ®Google Scholar
• Chen K, Preuss A, Hackbarth S, et al. Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations. J Photochem Photobiol B, Biol. 2009;96:66–74.
   PubMed Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, et al. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003;257:169–180.
   PubMed Web of Science ®Google Scholar
• Jun JY, Nguyen HH, Paik SYR, et al. Preparation of size controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem. 2011;127:1892–1898.
   Web of Science ®Google Scholar
• Sadeghi R, Moosavi-Movahedi AA, Eman-Jomeh Z, et al. The effect of diferente desolvating agentes on BSA nanoparticle properties and encapsulation of curcumin. J Nanopart Res. 2014;16:2565–2578.
   Web of Science ®Google Scholar
• Rao K, Naidu BVK, Subha MCS, et al. Novel chitosan-based pH-sensitive interpenetrating network microgels for the controlled release of cefadroxil. Carbohydr Polym. 2006;66:333–344.
   Web of Science ®Google Scholar
• Sailaja AK, Amareshwar P. Preparation of BSA nanoparticles by desolvation technique using acetone as desolvating agent. Int J Pharm Sci Nanotechnol. 2010;5:1643–1647.
   Google Scholar
• Rahimnejad M, Najafpour G, Bakeri G. Investigation and modeling effective parameters influencing the size of BSA protein nanoparticles as colloidal carrier. Colloid Surf A. 2012;412:96–100.
   Web of Science ®Google Scholar
• Sripriyalakshmi S, Anjali CH, Doss CGP, et al. BSA nanoparticle loaded atorvastatin calcium-a new facet for an old drug. PLoS ONE. 2014;9:e86317–e86326.
   PubMed Web of Science ®Google Scholar
• Dreis S, Rothweiler F, Michaelis M, et al. Preparation, characterization and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm. 2007;341:207–214.
   PubMed Web of Science ®Google Scholar
• Sebak S, Mirzaei M, Malhotra M, et al. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int J Nanomed. 2010;5:525–532.
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhao X, Zu Y, et al. Preparation, characterization and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed. 2010;5:669–677.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang D, Guo H, et al. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin. Int J Pharm. 2013;448:79–86.
   PubMed Web of Science ®Google Scholar
• Csaba N, Garcia-Fuentes M, Alonso MJ. The performance of nanocarriers for transmucosal drug delivery. Expert Opin Drug Deliv. 2006;3:463–478.
   PubMedGoogle Scholar
• Calixto GMF, Bernegossi J, de Freitas LM, et al. Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review. Molecules. 2016;21:342–359.
   PubMed Web of Science ®Google Scholar
• Yoon I, Li JZ, Shim YK. Advance in photosensitizers and light delivery for photodynamic therapy. Clin Endosc. 2013;46:7–23.
   PubMedGoogle Scholar
• Machado A. Terapia Fotodinâmica: Princípios, potencial de aplicação e perspectivas. Quím Nova. 2000;23:237–243.
   Google Scholar
• Gong J, Huo MR, Zhou JP, et al. Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles. Int J Pharm. 2009;376:161–168.
   PubMedGoogle Scholar
• Simplicio FI, Maionchi F, Hioka N. Photodynamic Therapy: Pharmacological aspects, applications and news from medications development. Quím. Nova. 2002;25:801–807.
   Web of Science ®Google Scholar
• Skrt M, Benedik E, Podlipnik C, et al. Interactions of different polyphenols with bovine serum albumin using fluorescence quenching and molecular docking. Food Chem. 2012;135:2418–2424.
   PubMed Web of Science ®Google Scholar
• Allison RR, Moghissi K. Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc. 2013;46:24–29.
   PubMedGoogle Scholar
• Lima AM, Pizzol CD, Monteiro FBF, et al. Hypericin encapsulated in solid lipid nanoparticles: Phototoxicity and photodynamic efficiency. J Photochem Photobiol B. 2013;125:146–154.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3:16–20.
   PubMed Web of Science ®Google Scholar
• Oliveira DM, Lacava ZGM, Lima ECD, et al. Zinc phthalocyanine/magnetic fluid complex: a promising dual nanostructured system for cancer treatment. J Nanosci Nanotech. 2006;6:2432–2437.
   PubMed Web of Science ®Google Scholar
• Siqueira-Moura MP, Primo FL, Espreafico EM, et al. Development, characterization, and photocytotoxicity assessment on human melanoma of chloroaluminum phthalocyanine nanocapsules. Mater Sci Eng C Mater Biol Appl. 2013;33:1744–1752.
   PubMed Web of Science ®Google Scholar